Bausch + Lomb (NYSE:BLCO) vs. Selectis Health (OTCMKTS:GBCS) Head-To-Head Contrast

Bausch + Lomb (NYSE:BLCO) and Selectis Health (OTCMKTS:GBCS) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Analyst Ratings

This is a breakdown of current ratings and target prices for Bausch + Lomb and Selectis Health, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch + Lomb	1	9	4	0	2.21
Selectis Health	0	0	0	0	0.00

Bausch + Lomb currently has a consensus price target of $17.92, suggesting a potential upside of 20.25%. Given Bausch + Lomb’s stronger consensus rating and higher possible upside, analysts clearly believe Bausch + Lomb is more favorable than Selectis Health.

Valuation and Earnings

This table compares Bausch + Lomb and Selectis Health”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch + Lomb	$5.10 billion	1.04	-$360.00 million	($0.62)	-24.03
Selectis Health	$41.44 million	0.24	-$1.02 million	($0.34)	-9.41

Selectis Health has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Selectis Health, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Bausch + Lomb and Selectis Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bausch + Lomb	-4.21%	3.60%	1.69%
Selectis Health	-2.45%	N/A	-3.03%

Volatility & Risk

Bausch + Lomb has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, Selectis Health has a beta of -1.07, meaning that its share price is 207% less volatile than the S&P 500.

Insider & Institutional Ownership

11.1% of Bausch + Lomb shares are owned by institutional investors. 1.5% of Bausch + Lomb shares are owned by insiders. Comparatively, 15.2% of Selectis Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Bausch + Lomb beats Selectis Health on 9 of the 14 factors compared between the two stocks.

About Bausch + Lomb

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.

About Selectis Health

Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.